Broker Ratings

Waters Corporation – Consensus ‘hold’ rating and -1.9% Downside Potential

Waters Corporation with ticker code (WAT) have now 14 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The range between the high target price and low target price is between $350.00 and $300.00 with the average target price sitting at $324.93. Given that the stocks previous close was at $331.25 this indicates there is a potential downside of -1.9%. The 50 day moving average now sits at $319.13 and the 200 moving average now moves to $281.29. The company has a market cap of 19.34B. The stock price for the company is currently $327.03 USD

The potential market cap would be $18,967,380,532 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 30.22, revenue per share of $50.04 and a 13.84% return on assets.

Waters Corporation is a specialty measurement company. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments. The Company’s products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic and government customers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Waters Corporation (WAT) Stock Analysis: Navigating a 1.76% Potential Upside Amid Strong Return on Equity

    Waters Corporation (WAT), a prominent player in the healthcare sector, is renowned for its sophisticated analytical workflow solutions. Operating across Asia, the Americas, and Europe, Waters has carved a niche

    Waters Corporation (WAT) Stock Analysis: Navigating a Healthcare Giant with Strong Revenue Growth and Robust Analyst Support

    Waters Corporation (NYSE: WAT), a leader in the diagnostics and research industry within the healthcare sector, presents a compelling investment narrative with its robust revenue growth and high analyst interest.

    Waters Corporation (WAT) Stock Analysis: A Promising 5.92% Potential Upside for Healthcare Investors

    Waters Corporation (NYSE: WAT), a significant player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market capitalization of $19.92

    Waters Corporation (WAT) Investor Outlook: Exploring a 6% Upside with Robust Revenue Growth

    Waters Corporation (WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing the attention of investors with its innovative solutions and consistent

    Waters Corporation (WAT) Stock Analysis: Navigating a 5.41% Potential Upside in the Healthcare Sector

    Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, stands as a significant entity for investors seeking exposure to analytical workflow

    Waters Corporation (WAT) Stock Analysis: Navigating a 19% Potential Upside with Strategic Insights

    Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector’s diagnostics and research industry, continues to be a focal point for investors seeking opportunities within analytical workflow solutions. With a

      Search

      Search